For people with pancreatitis, a noncancerous inflammation of the tiny ducts in the 6-inch organ, the discomfort can be devastating.
After undergoing surgery to remove diseased sections of the colon, up to 30 percent of patients experience leakage from their sutures, which can cause life-threatening complications.
Cells are incredibly complicated machines with thousands of interacting parts — and disruptions to any of those interactions can cause disease.
An Arizona hospital is testing medicines very early in development and never tried on brain tumors before.
A new study demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system’s vigilance against tumor cells.
Pancreatic cancer is one of the most deadly forms of cancer, with only 6 percent of patients surviving five years after diagnosis. Today, Cold Spring Harbor Laboratory (CSHL) and The Lustgarten Foundation jointly announce the development of a new model system to grow both normal and cancerous pancreatic cells in the laboratory.
The drugs were designed to keep cancer cells at bay by preventing their growth, survival and spread. Yet, after clinical trials, they left scientists scratching their heads and drug developers watching their investments succumb to cancer’s latest triumph.
Fibrosis is a constant feature of all chronic liver diseases.
When 2 milliliters of blood are run through the chip, the tumor cells stick to the nanowires like Velcro.
For the first time, the genome of a mammal longer-lived than man has been sequenced: the bowhead whale, who lives 200-plus years, and gets far less cancer given its size.
In the race to find a safe and effective weight loss drug, much attention has focused on the chemical processes that store and use energy.
The fingers of papillary tumors often grow back after surgery, but flat carcinoma in situ cancers are typically more aggressive and more likely to spread.
Adding radiation treatment to hormone therapy saves more lives among older men with locally advanced prostate therapy than hormone therapy alone.
Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.
Patients are benefitting from new technology that detects microscopic amounts of cancer cells on removed tumor tissue not visible during or following surgical intervention.
The idea that breast cancer becomes more prevalent with age is fairly well established, but the reasons why are still uncertain. Now, scientists from the Lawrence Berkeley National Laboratory have new insights into why older women are more susceptible to breast cancer.
Some of the most important advances in breast cancer this year were related to all kinds of heterogeneity: within tumors, between tumors in a single patient, and between tumors in early and later stages, according to oncologists speaking at conferences, and contacted by Bioscience Technology.
Cell biologists at UT Southwestern Medical Center have targeted telomeres with a small molecule called 6-thiodG that takes advantage of the cell’s “biological clock” to kill cancer cells and shrink tumor growth.
Scientists from the Johns Hopkins Kimmel Cancer Center have created a statistical model that measures the proportion of cancer incidence, across many tissue types, caused mainly by random mutations that occur when stem cells divide.
The body has evolved ways to get rid of faulty stem cells.
Cancer Research UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells - meaning they can break loose and spread, according to research published in Cell Reports.
An international research team, including four Simon Fraser University scientists, has identified the "mutational landscape" of intrahepatic cholangiocarcinoma (ICC), a rare, highly fatal form of liver cancer that disproportionately affects people in Asian countries.
UT Southwestern Medical Center cancer researchers have demonstrated that whole-genome sequencing can be used to identify patients' risk for hereditary cancer, which can potentially lead to improvements in cancer prevention, diagnosis, and care.
Scientists at The Scripps Research Institute have found that this red-wine ingredient once touted as an elixir of youth, powerfully activates an evolutionarily ancient stress response in human cells.
Developing effective treatments for lung cancer has been challenging, in part because so many genetic mutations play a role in the disease. By analyzing the DNA and RNA of lung cancers, researchers at the University of Michigan Comprehensive Cancer Center found that patients whose tumors contained a large number of gene fusions had worse outcomes than patients with fewer gene fusions.